Is tetrabenazine safe and effective for suppressing chorea in Huntington's disease?

被引：0
|
作者：
Blair R Leavitt
Michael R Hayden
机构：
[1] neurologist in the Neurogenetics and Huntington Disease Medical Clinics of the University of British Columbia,
[2] and scientist and Director of the Transgenic Facility at the Centre for Molecular Medicine and Therapeutics in Vancouver,undefined
[3] full professor of Medical Genetics at the University of British Columbia,undefined
[4] and Director of the Centre for Molecular Medicine and Therapeutics in Vancouver,undefined
来源：
Nature Clinical Practice Neurology | 2006年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：536 / 537
页数：1
相关论文
共 50 条
  • [21] Long-term safety and efficacy of tetrabenazine in the treatment of chorea associated with Huntington's disease
    Shen, V.
    Clarence-Smith, K.
    Hunter, C.
    Jankovic, J.
    MOVEMENT DISORDERS, 2012, 27 : S60 - S60
  • [22] Safety and tolerability of tetrabenazine use with concomitant medications in Huntington's chorea
    Jog, M. S.
    Khandekar, N.
    Attar, A.
    MOVEMENT DISORDERS, 2006, 21 (09) : 1555 - 1555
  • [23] Long-Term Safety and Efficacy of Tetrabenazine in the Treatment of Chorea Associated with Huntington's Disease
    Shen, Vivienne
    Clarence-Smith, Kathleen
    Hunter, Christine
    Jankovic, Joseph
    NEUROLOGY, 2012, 78
  • [24] Tolerability of tetrabenazine in Huntington's disease
    Jog, M.
    Khandekar, N.
    Attar, A.
    MOVEMENT DISORDERS, 2006, 21 : S357 - S358
  • [25] Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
    Frank, Samuel
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 657 - 665
  • [26] Demographic and Clinical Characteristics and Tetrabenazine (TBZ) Persistence in Patients with Huntington's disease (HD)-Associated Chorea
    Sung, V.
    Iyer, R.
    Gandhi, S.
    Abler, V.
    Davis, B.
    Irwin, D.
    Anderson, K.
    MOVEMENT DISORDERS, 2017, 32
  • [27] An open label study of tetrabenazine as anti-Chorea therapy in Huntington disease
    Frank, Samuel A.
    NEUROLOGY, 2007, 68 (12) : A365 - A365
  • [28] Tetrabenazine is neuroprotective in Huntington's disease mice
    Wang, Hongyu
    Chen, Xi
    Li, Yuemei
    Tang, Tie-Shan
    Bezprozvanny, Ilya
    MOLECULAR NEURODEGENERATION, 2010, 5
  • [29] Tetrabenazine is neuroprotective in Huntington's disease mice
    Hongyu Wang
    Xi Chen
    Yuemei Li
    Tie-Shan Tang
    Ilya Bezprozvanny
    Molecular Neurodegeneration, 5
  • [30] Management of Huntington's disease: role of tetrabenazine
    de Tommaso, Marina
    Serpino, Claudia
    Sciruicchio, Vittorio
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2011, 7 : 123 - 129
12345